| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |